Abstract:Oncogene-induced senescence (OIS) is an important tumor suppression mechanism preventing uncontrolled proliferation in response to aberrant oncogenic signaling. The profound functional and morphological remodelling of the senescent cell involves extensive changes. In particular, alterations in protein ubiquitination during senescence have not been systematically analyzed previously. Here, we report the first global ubiquitination profile of primary human cells undergoing senescence. We employed a well-characterized in vitro model of OIS, primary human fibroblasts expressing oncogenic RAS. To compare the ubiquitinome of RAS-induced OIS and controls, ubiquitinated peptides were enriched by immune affinity purification and subjected to liquid chromatography tandem mass spectrometry (LC-MS/MS). We identified 4,472 ubiquitination sites, with 397 sites significantly changed (>3 standard deviations) in senescent cells. In addition, we performed mass spectrometry analysis of total proteins in OIS and control cells to account for parallel changes in both protein abundance and ubiquitin levels that did not affect the percentage of ubiquitination of a given protein. Pathway analysis revealed that the OIS-induced ubiquitinome alterations mainly affected 3 signaling networks: eIF2 signaling, eIF4/p70S6K signaling, and mTOR signaling. Interestingly, the majority of the changed ubiquitinated proteins in these pathways belong to the translation machinery. This includes several translation initiation factors (eIF2C2, eIF2B4, eIF3I, eIF3L, eIF4A1) and elongation factors (eEF1G, eEF1A) as well as 40S (RPS4X, RPS7, RPS11 and RPS20) and 60S ribosomal subunits (RPL10, RPL11, RPL18 and RPL35a). In addition, we observed enriched ubiquitination of aminoacyl-tRNA ligases (isoleucyl-, glutamine-, and tyrosine-tRNA ligase), which provide the amino acid-loaded tRNAs for protein synthesis. These results suggest that ubiquitination affects key components of the translation machinery to regulate protein synthesis during OIS. Our results thus point toward ubiquitination as a hitherto unappreciated regulatory mechanism during OIS.

Nuclear phosphoproteome reveals Prolyl Isomerase PIN1 as a modulator of oncogene-induced senescence

Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer

Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts

Mitotic Stress is an Integral Part of the Oncogene-Induced Senescence Program That Promotes Multinucleation and Cell Cycle Arrest

The Oncogene PIM1 Contributes to Cellular Senescence by Phosphorylating Staphylococcal Nuclease Domain-Containing Protein 1 (SND1)

Oncogene-induced senescence: From biology to therapy

Protein Kinase D1 is Essential for Ras-Induced Senescence and Tumor Suppression by Regulating Senescence-Associated Inflammation

Titration of RAS alters senescent state and influences tumour initiation

Oncogenic Hijacking of the PIN1 Signaling Network

Prolyl Isomerase Pin1 in Cancer.

Nqo1 Stabilizes P53 In Response To Oncogene-Induced Senescence

Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence

Oncogene-induced senescence: a potential breakpoint mechanism against malignant transformation in plasma cell disorders

Selective degradation of ribosomes during oncogene-induced senescence: molecular insights and biological perspectives

The Protein Kinase D1-mediated Classical Protein Secretory Pathway Regulates the Ras Oncogene-Induced Senescence Response.

Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor

The SCN9A channel and plasma membrane depolarization promote cellular senescence through Rb pathway

PIM1 Induces Cellular Senescence Through Phosphorylation of UHRF1 at Ser311

Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role

Retinoblastoma protein promotes oxidative phosphorylation through upregulation of glycolytic genes in oncogene-induced senescent cells

Gain-of-Function p53N236S Mutation Drives the Bypassing of HRasV12-Induced Cellular Senescence via PGC–1α